Healthcare Finance Staff
CMS has announced a follow-up Special Open Door Forum conference call on Sept. 26 on the "two midnights" benchmark. It's intended to allow hospitals and other providers to ask questions on the FY14 physician order and physician certification, inpatient hospital admission and medical review criteria in the IPPS/LTCH final rule.
Sticking with its risk-based approach, the U.S. Food and Drug Administration has issued final guidance for mobile medical application developers, promising limited regulation for most health and wellness apps.
Medical researchers have found primary care physicians who participated in a quality-reporting incentive program making modest progress in cardiovascular disease preventive care.
The growth rate of healthcare spending among those with private, employer-sponsored health insurance rose 4 percent in 2012, slightly lower than the previous year, but with more dollars spent on outpatient care and out-of-pocket expenses, according to the Health Care Cost Institute.
Aetna is expanding its accountable care relationship with the Sharp HealthCare system, introducing a new insurance product for large group members in greater San Diego.
The Centers for Medicare & Medicaid Services (CMS) issued a final rule on Medicaid payments to disproportionate share hospitals (DSH) last week, cutting approximately $1.1 billion from the program over the next two fiscal years.
There is a "wide gap" between financial experts and the public at large on the issue of Medicare's financial state, according to the New England Journal of Medicine.
Much of the marketing to potential enrollees of health insurance exchanges has been conducted by health insurers and other organizations advancing the marketplaces, but health systems have a role to play in signing up individuals that could also benefit their bottom line.
A group of physicians hoping to offer new imaging and colonoscopy services in Virginia are facing an uphill battle trying to overturn the commonwealth's "certificate of need" law.
Low-cost standalone prescription drug plans for Medicare Part D have been growing in market share, accounting for 16 percent of drug plans, according to an analysis of federal data by Avalere Health.